Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.56 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14345183 | 0.90 | ATM (0.81) | ATMPOLBALDH1A1CACNA1BAPBA1 | |
| SCHEMBL3180354 | 0.81 | ATM (0.69) | ATMPOLBALDH1A1CACNA1BAPBA1 | |
| SCHEMBL13870645 | 0.81 | ATM (0.69) | ATMPOLBALDH1A1CACNA1BAPBA1 | |
| SCHEMBL3180344 | 0.81 | ATM (0.69) | ATMPOLBALDH1A1CACNA1BAPBA1 | |
| SCHEMBL1104580 | 0.81 | ATM (0.69) | ATMALDH1A1CACNA1BAPBA1MAPT | |
| SCHEMBL5891287 | 0.81 | ATM (0.69) | ATMPOLBALDH1A1CACNA1BAPBA1 | |
| SCHEMBL13480903 | 0.81 | ATM (0.69) | ATMPOLBALDH1A1CACNA1BAPBA1 | |
| SCHEMBL18804483 | 0.81 | MEN1 (0.72) | ATMPOLBALDH1A1CACNA1BAPBA1 | |
| SCHEMBL13936105 | 0.80 | ATM (0.67) | ATMPOLBALDH1A1CACNA1BAPBA1 | |
| SCHEMBL17616369 | 0.80 | ATM (0.67) | ATMPOLBALDH1A1CACNA1BAPBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8223472-B1 | Norbornylene-based polymer systems for dielectric applications | SANDIA CORPORATION (US) | 2012-07-17 | — | — | US | claimed |
| US-3954913-A | THERMAL DISCOLORATION INHIBITION | THE STANDARD OIL COMPANY (US) | 1976-05-04 | — | — | US | claimed |
| EP-2977098-B1 | A POROUS MEMBRANE PREPARED FROM A SELF-ASSEMBLING BLOCK-COPOLYMER AS WELL AS A METHOD FOR MAKING SAME | PALL CORP (US) | 2018-07-18 | — | — | EP | disclosed |
| US-9856353-B2 | Optical film and display device including same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-01-02 | — | — | US | disclosed |
| US-9616395-B2 | Membrane comprising self-assembled block copolymer and process for producing the same by spray coating (Ic) | Pall Corportaion (US) | 2017-04-11 | — | — | US | disclosed |
| US-9604181-B2 | Membrane comprising self-assembled block copolymer and process for producing the same by spray coating (IIc) | PALL CORPORATION (US) | 2017-03-28 | — | — | US | disclosed |
| US-9604181-B2 | Membrane comprising self-assembled block copolymer and process for producing the same by spray coating (IIc) | PALL CORPORATION (US) | 2017-03-28 | — | — | US | disclosed |
| US-9593218-B2 | Self-assembled structure and membrane comprising block copolymer and process for producing the same by spin coating (IIIa) | PALL CORPORATION (US) | 2017-03-14 | — | — | US | disclosed |
| US-9592476-B2 | Membrane comprising self-assembled block copolymer and process for producing the same by hybrid casting (IIb) | PALL CORPORATION (US) | 2017-03-14 | — | — | US | disclosed |
| US-9592476-B2 | Membrane comprising self-assembled block copolymer and process for producing the same by hybrid casting (IIb) | PALL CORPORATION (US) | 2017-03-14 | — | — | US | disclosed |
| US-9593219-B2 | Membrane comprising self-assembled block copolymer and process for producing the same by spin coating (IIa) | PALL CORPORATION (US) | 2017-03-14 | — | — | US | disclosed |
| US-20090131682-A1 | SUPPORTS FOR OLIGOMER SYNTHESIS | ISIS PHARMACEUTICALS, INC. (US) | 2009-05-21 | — | — | US | disclosed |
| US-7378533-B1 | Method for preparing thermally cleavable surfactants without deprotonation | SANDIA CORPORATION (US) | 2008-05-27 | — | — | US | disclosed |
| US-7351837-B1 | Thermally cleavable surfactants without deprotonation | SANDIA CORPORATION (US) | 2008-04-01 | — | — | US | disclosed |
| US-20080021224-A1 | SUPPORTS FOR OLIGOMER SYNTHESIS | ISIS PHARMACEUTICALS, INC. (US) | 2008-01-24 | — | — | US | disclosed |
| US-20080021224-A1 | SUPPORTS FOR OLIGOMER SYNTHESIS | ISIS PHARMACEUTICALS, INC. (US) | 2008-01-24 | — | — | US | disclosed |
| US-7202264-B2 | Supports such as glass and styrene polymers functionalized with tricyclic hetercyclic anhydrides and imides, used in the preparation of oligonucleotides | ISIS PHARMACEUTICALS, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| US-7202264-B2 | Supports such as glass and styrene polymers functionalized with tricyclic hetercyclic anhydrides and imides, used in the preparation of oligonucleotides | ISIS PHARMACEUTICALS, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| US-20040152905-A1 | Universal building blocks and support media for synthesis of oligonucleotides and their analogs | ISIS PHARMACEUTICALS, INC. | 2004-08-05 | — | — | US | disclosed |
| US-3954913-A | THERMAL DISCOLORATION INHIBITION | THE STANDARD OIL COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131682-A1 | SUPPORTS FOR OLIGOMER SYNTHESIS | ILK, NOP2, PFAS | ATM 3498/4885POLB 512/4885ALDH1A1 4121/4885 |
| US-20080021224-A1 | SUPPORTS FOR OLIGOMER SYNTHESIS | ILK, NOP2, PFAS | ATM 3498/4885POLB 512/4885ALDH1A1 4121/4885 |
| US-20040152905-A1 | Universal building blocks and support media for synthesis of oligonucleotides and their analogs | POLM, POLRMT, POLB | ATM 2948/4885POLB 3/4885ALDH1A1 4408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.